Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

U.S. Court of Appeals Upholds Validity of Lilly's Evista Patents Through March of 2014

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, Sept. 1 /- Eli Lilly and Company (NYSE: LLY ) today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista®...

TOPICS:

The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

COLD SPRING HARBOR, N.Y., Sept. 1 /- The ASCO Post captured initial reactions to the Oncologic Drugs Advisory Committee (ODAC) recommendation that the breast cancer indication for bevacizumab (Avastin) be revoked in interviews with ODAC voting members, breast cancer specialists,...

TOPICS:

QRxPharma Announces Interim Analysis of Final Pivotal Phase 3 Study for MoxDuo®IR

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

SYDNEY, Australia and BEDMINSTER, N.J., Sept. 1 /- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today a successful interim analysis of its final MoxDuo IR pivotal Phase 3 study required for New Drug Application (NDA) submission. The analysis indicated the planned sample size of 140...

TOPICS:
Advertisement

NCPA Launches www.PharmacyMatching.com to Connect Independent Pharmacy Buyers and Sellers

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

ALEXANDRIA, Va., Sept. 1 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association today announced the launch of a new website, www.PharmacyMatching.com to bring together independent pharmacy owners preparing to sell their pharmacy, existing owners who desire additional...

TOPICS:

Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance Initiative

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Sept. 1 /- Radiation Oncology Services of America, Inc. (ROSA), a subsidiary of Ambulatory Services of America, Inc. (ASA), announced today that it has entered into an agreement with the Department of Radiation Oncology at the Washington University in St. Louis School of...

TOPICS:

MedWOW Adds Comparison Tool for Shoppers' Medical Equipment - Offers eBook Free to New Registrants

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

NICOSIA, Cyprus, Sept. 1 /- MedWOW.com, the global online marketplace for medical equipment , is pleased to announce the addition of its newest consumer-focused tool: a comparison feature that allows buyers to select as many items as they would like to compare, assisting them in making...

TOPICS:

Volunteers needed for calorie consumption and exercise study

September 1, 2010 11:35 am | by Baylor College of Medicine | News | Comments

The USDA/ARS Children's Nutrition Research Center at Baylor College of Medicine is recruiting volunteers to participate in a two-visit study for healthy 3- to 5 -year-olds. The purpose of the study is to develop a method to determine calories used in young children by having them wear...

TOPICS:

Unilife Corporation Secures FDA 510k Clearance for the Unitract™ 1mL Tuberculin Syringe

September 1, 2010 11:35 am | by Bio-Medicine.Org | News | Comments

LEWISBERRY, Pa., Sept. 1 /- Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS, ASX: UNS), today announced that its Unitract™ Tuberculin (TB) Syringe has received  510(k) market clearance from the U.S. Food and Drug Administration (FDA).   The Unitract™ TB...

TOPICS:
Advertisement

Metformin May Protect Against Lung Cancer

September 1, 2010 11:33 am | by AACR | News | Comments

PHILADELPHIA — Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors, according to early research conducted at the National Cancer Institute (NCI).

TOPICS:

Federal Register: Public Workshop on Medical Devices and Nanotechnology: Manufacturing, Characterization, and Biocompatibility Considerations; Correction.

September 1, 2010 11:31 am | by U.S. Food & Drug Administration | News | Comments

The FDA is correcting a notice that appeared in the Federal Register of August 23, 2010 (75 FR 51829). The notice announced the public workshop entitled 'Medical Devices & Nanotechnology: Manufacturing, Characterization, and Biocompatibility...

TOPICS:

Federal Register: Medical Device User Fee Act; Public Meeting; Request for Comments; Amendment of Notice

September 1, 2010 11:31 am | by U.S. Food & Drug Administration | News | Comments

The FDA is announcing an amendment to the notice of a public meeting on the reauthorization of the medical device user fee program. This meeting was announced in the Federal Register of August 13, 2010 (75 FR 49502). The amendment is being made to...

TOPICS:

Tygacil (tigecycline): Label Change - Increased Mortality Risk

September 1, 2010 11:30 am | by U.S. Food & Drug Administration | News | Comments

Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.

TOPICS:

‘ZPrinted’ 3D Models Help Improve Oral Surgery

September 1, 2010 11:17 am | by Z Corporation | Articles | Comments

Planmeca Oy, the largest privately owned high-tech dental equipment maker, is using Z Corporation 3D printing technology to transform maxillofacial surgery, leading to shorter procedures, reduced hospital stays, lower health-care costs and improved patient outcomes.

TOPICS:

Omnicare buys Continuing Care Rx

September 1, 2010 9:45 am | by The Associated Press | News | Comments

Omnicare Inc., which dispenses drugs to nursing homes and long-term care facilities, said Wednesday it bought privately held Continuing Care Rx for an undisclosed amount.Continuing Care, based in Harrisburg, Pa., provides pharmacy services to residents of long-term care and other facilities in...

LHC Group acquires home health agency

September 1, 2010 8:45 am | by The Associated Press | News | Comments

Home health provider LHC Group Inc. says it has acquired the assets of a home health agency in Harrodsburg, Ky.Terms of the deal with James B. Haggin Memorial Hospital were not revealed. Lafayette-based LHC Group will take over the operations of Haggin Home Health. The agency will be renamed...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading